The Cancer Prevention & Research Institute of Texas (CPRIT) has released three (3) RFAs for
Cancer Product Development grants.
Deadline for these opportunities is August 7, 2019
These grants include:
- Texas Company Product Development Research Awards (TXCO)
This award mechanism seeks to support early-stage “start-up” and established companies in the development of innovative products, services, and infrastructure with significant potential impact on patient care. The proposed project must further the development of new products for the diagnosis, treatment, or prevention of cancer; must establish infrastructure that is critical to the development of a robust industry; or must fill a treatment or research gap. Companies must be headquartered in Texas.
Please note that in any given application round, applicants may apply for one Product Development award (TXCO, RELCO or Seed) at a time. Applicants are advised to review each RFA and select the program that best fits their development status. Please see the RFAs for additional instructions.
Award: Maximum amount $20M; Maximum duration of 36 months.
A webinar held on May 23, 2019 regarding this RFA is available.
Instructions for Applicants
- Company Relocation Product Development Research Awards (RELCO)
This award mechanism seeks to support early-stage “start-up” and established companies in the development of innovative products, services, and infrastructure with significant potential impact on patient care. The proposed project must further the development of new products for the diagnosis, treatment, or prevention of cancer; must establish infrastructure that is critical to the development of a robust industry; or must fill a treatment or research gap. Companies must relocate to Texas upon receipt of award.
Please note that in any given application round, applicants may apply for one Product Development award (TXCO, RELCO or Seed) at a time. Applicants are advised to review each RFA and select the program that best fits their development status. Please see the RFAs for additional instructions.
Award: Maximum amount $20M; Maximum duration of 36 months.
A webinar held on May 23, 2019 regarding this RFA is available.
Instructions for Applicants
- Seed Awards for Product Development Research (SEED)
This award mechanism seeks to support projects that are too early in their development timeline to be eligible for CPRIT’s two other Product Development Awards, the Texas Company Award (TXCO) and the Company Relocation Award (RELCO). The proposed project must further the development of new products for the diagnosis, treatment, or prevention of cancer; must establish infrastructure that is critical to the development of a robust industry; or must fill a treatment or research gap. Company applicants must be headquartered in Texas or be willing to relocate to Texas upon receipt of award.
Please note that in any given application round, applicants may apply for one Product Development award (TXCO, RELCO or Seed) at a time. Applicants are advised to review each RFA and select the program that best fits their development status. Please see the RFAs for additional instructions.
Award: Maximum amount of $3M; Maximum duration of 36 months.
A webinar held on May 23, 2019 regarding this RFA is available.
Instructions for Applicants
All Proposals must be submitted through CPRIT’s online grant application system. Complete RFAs detailing deadlines, requirements, and instructions are available in the Funding Opportunities section of CPRIT’s website.
Please direct questions regarding these funding opportunities to Rosemary French, Senior Program Manager for Product Development, rfrench@cprit.texas.gov, 512-305-7676.